AT1 receptor antagonist, TCV 116, does not prevent cardiac hypertrophy in salt-loaded Dahl salt-sensitive rats

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 4, 1996, Pages 282-286

  Sugimoto, Koh Ichi ^a,b   Gotoh, Eiji ^a   Takasaki, Izumi ^a   Ebina, Toshiaki ^a   Iwamoto, Tamio ^a   Takizawa, Toshikazu ^a   Shionoiri, Hiroshi ^a   Ishii, Masao ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

AT1 receptor antagonist; cardiac hypertrophy; Dahl salt sensitive rat; hypertension; salt loading

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN HEXETIL; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; BIPHENYL DERIVATIVE; PRODRUG; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART HYPERTROPHY; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SALT INTAKE; ANIMAL; BLOOD PRESSURE; BODY WEIGHT; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HEART LEFT VENTRICLE HYPERTROPHY; RANDOMIZATION; SODIUM INTAKE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; BLOOD PRESSURE; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; PRODRUGS; RANDOM ALLOCATION; RATS; RECEPTORS, ANGIOTENSIN; SODIUM, DIETARY; TETRAZOLES;

EID: 0029664845     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb02824.x     Document Type: Article

References (24)

1. Grinstead WC, Young JB. The myocardial renin-angiotensin system: Existence, importance, and clinical implications. Am. Heart J. 1992; 123: 1039-45.
2. Pfeffer JM, Pfeffer MA, Mirsky I, Braunwald E. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. Proc. Natl Acad. Sci. USA 1982; 79: 3310-14.
3. Freslon JL, Giudicelli JF. Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br. J. Pharmacol. 1983; 80: 533-43.
4. Clozel J-P, Kuhn H, Heffti F. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. J. Hypertens. 1989; 7: 267-75.
5. Kromer EP, Rieger GAJ. Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat. Am. J. Cardiol. 1988; 62: 161-3.
6. Baker KE, Chemin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am. J. Physiol. 1990; 259: H324-32.
7. Schölkens BA, Linz W, Martorana PA. Experimental cardiovascular benefits of angiotensin-converting enzyme inhibitors: Beyond blood pressure reduction. J. Cardiovasc. Pharmacol. 1991; 18 (Suppl. 2): S26-30.
8. Kang PM, Landau AJ, Eberhardt RT, Frishman WH. Angiotensin II receptor antagonists: A new approach to blockade of the renin-angiotensin system. Am. Heart J. 1994; 127: 1388-401.
9. Camargo MJF, von Lutterotti N, Campbell WG Jr et al. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade. J. Hypertens. 1993; 11: 31-40.
10. Mizuno K, Niimura S, Katoh K, Fukuchi S. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats. Life Sci. 1994; 54: 1987-94.
11. 1 receptor antagonist, and surgical reversal. J. Cardiovasc. Pharmacol. 1994; 23: 291-9.
12. Rapp JP. Dahl salt-susceptible and salt-resistant rats. Hypertension 1982; 4: 753-63.
13. von Lutterrotti N, Camargo MJF, Muller FB, Timmermans PBMWM, Laragh JH. Angiotensin II receptor antagonist markedly reduces mortality in salt-loaded Dahl S rats. Am. J. Hypertens. 1991; 4: S346-9.
14. Sugimoto K, Gotoh E, Takasaki I et al. Cardiac hypertrophy and the blockade of angiotensin II receptors by losartan in salt-loaded Dahl salt-sensitive rats. Hypertens. Res. 1994; 17: 199-203.
15. Inada Y, Wada T, Shibouta Y et al. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist (±)-1(cyclohexyloxycarbonyloxy) ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl] methyl]-1H-benzimidazole-7 carboxylate (TCV-116), in various hypertensive rats. J. Pharmacol. Exp. Ther. 1993; 268: 1540-7.
16. Kohara K, Mikami H, Okuda N, Higaki J, Ogihara T. Angiotensin blockade and the progression of renal damage in the spontaneously hypertensive rat. Hypertension 1993; 21: 975-9.
17. Yoshiyama M, Kim S, Yamagishi H et al. Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury. Am. Heart J. 1994; 128: 1-6.
18. 1 receptor subtype. Circ. Res. 1993; 73: 413-23.
19. Kojima M, Shiojima I, Yamazaki T et al. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation 1994; 89: 2204-11.
20. Rapp JP, McPartland RP, Sustarsic DL. A qualitative difference in plasma renin activity in Dahl rats susceptible or resistant to salt-induced hypertension. Biochem. Gen. 1980; 18: 1087-96.
21. Sharma JN, Fernandez PG, Kim BK, Idikio H, Triggle CR. Cardiac regression and blood pressure control in the Dahl rat treated with either enalapril maleate (MK 421, an angiotensin converting enzyme inhibitor) or hydrochlorothiazide. J. Hypertens. 1983; 1: 251-6.
22. Fernandez D, Bolli P, Snedden W, Vasdev S, Fernandez PG. Modulation of left ventricular hypertrophy by dietary salt and inhibition of angiotensin converting enzymes. J. Hypertens. 1988; 6(Suppl. 4): S145-7.
23. De Simone G, Devereux RB, Camargo MJF, Wallerson DC, Laragh JH. Effect of angiotensin II receptor inhibition on left ventricular anatomy in salt-loaded Dahl rats. Circulation 1993; 88 (Suppl. I): I416.
24. von Lutterrotti N, Camargo MJF, Campbell WG Jr et al. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats. J. Hypertens. 1992; 10: 949-57.